Virtual Molecular Tumor Board in NSCLC: Expert Advice on Challenging Cases

More details

Updates in Oncogene-Driven NSCLC from Paris

More details

Join the ACE Oncology Network Today!

Discover the latest updates in oncology, and engage with experts in the field.

JOIN ACE ONCOLOGY NOW

Upcoming Events

See All Upcoming Events
Virtual Molecular Tumor Board in NSCLC: Expert Advice on Challenging Cases

Virtual Molecular Tumor Board in NSCLC: Expert Advice on Challenging Cases

This live, virtual molecular tumor board meeting will include an...

Online Education

See All Online Education

CME

article-thumbnail

Updates in Oncogene-Driven NSCLC from Paris

4 videos / 4 slide decks

CME

article-thumbnail

Updates in Oncogene-Driven NSCLC from Vienna

3 videos / 3 slide decks

CME

article-thumbnail

Expert Review

Innovative Strategies in Locally Advanced Head and Neck Cancer:
Focus on Targeting Inhibitor of Apoptosis Proteins

3 videos / 3 slide decks
article-thumbnail

On-Demand Presentations and Slides

Multidisciplinary Treatment Strategies in CRC to Optimize Patient Outcomes

11 videos / 11 slide decks

Latest Blogs

See Latest Blogs
FDA Approved 3 New Indications in Oncology in June-July 2022

FDA Approved 3 New Indications in Oncology in June-July 2022

The US FDA approved three new indications for cancer management...
Intensive Follow-up Does Not Improve Survival in Endometrial Cancer

Intensive Follow-up Does Not Improve Survival in Endometrial Cancer

Endometrial cancer is among the most common gynecological cancers in...
Adjuvant Toripalimab vs. High-Dose Interferon in Mucosal Melanoma: Similar Efficacy, Better Tolerability

Adjuvant Toripalimab vs. High-Dose Interferon in Mucosal Melanoma: Similar Efficacy, Better Tolerability

Mucosal melanoma (MM) is rare in the West, but in...
Acetaminophen May Hinder Immunotherapy Efficacy in Cancer

Acetaminophen May Hinder Immunotherapy Efficacy in Cancer

Immune checkpoint inhibitors (ICIs) have changed the paradigm of cancer...